My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemed Corp (NY:CHE)

462.23 +11.77 (+2.61%)
Official Closing Price Updated: 7:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemed Corp

< Previous 1 2 3 4 5 6 7 Next >
Peering Into Chemed's Recent Short Interest
 
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $13,000 Today
 
Via Benzinga
Here's How Much You Would Have Made Owning Chemed Stock In The Last 20 Years
 
Via Benzinga
Exxon Mobil, Chemed, Las Vegas Sands And More On CNBC's 'Final Trades'
Joshua Brown of Ritholtz Wealth Management picked an oil ETF as a hedge against Iran, while Jim Lebenthal of Cerity Partners picked Exxon. 
Via Benzinga
Topics ETFs
Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
From Chemed Corporation
Via Business Wire
Looking Into Chemed's Recent Short Interest
 
Via Benzinga
How Is The Market Feeling About Chemed?
 
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
 
Via Benzinga
(CHE) - Analyzing Chemed's Short Interest
 
Via Benzinga
3 Ways to Play the Long-Term Care Crisis in 2024
As America’s population ages, long-term care stocks will become more attractive to investors. Here are three that already are. 
Via InvestorPlace
Chemed Corporation Declares Quarterly Dividend of 50 Cents
From Chemed Corporation
Via Business Wire
CHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q2 2024
CHE stock results show that Chemed missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Chemed Reports Second-Quarter 2024 Results
From Chemed Corporation
Via Business Wire
Peering Into Chemed's Recent Short Interest
 
Via Benzinga
(CHE) - Analyzing Chemed's Short Interest
 
Via Benzinga
Chemed Corp. (NYSE: CHE) is a Leading Gainer in Wednesday Morning Trading
Via Investor Brand Network
Chemed: Q4 Earnings Insights
 
Via Benzinga
Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25
From Chemed Corporation
Via Business Wire
Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference
From Chemed Corporation
Via Business Wire
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
From Chemed Corporation
Via Business Wire
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
From Chemed Corporation
Via Business Wire
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Chemed: Dividend Insights
 
Via Benzinga
CHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q1 2024
CHE stock results show that Chemed missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Chemed Reports First-Quarter 2024 Results
From Chemed Corporation
Via Business Wire
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
From Chemed Corporation
Via Business Wire
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
From Chemed Corporation
Via Business Wire
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
From Chemed Corporation
Via Business Wire
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
From Chemed Corporation
Via Business Wire
Chemed Reports Fourth-Quarter 2023 Results
From Chemed Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.